Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05367271 · ClinicalTrials.gov registry record · Phase 2
The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis
A Phase 2 study, sponsored by Western Institute for Veterans Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT05367271 is a Phase 2 study that has completed, run by Western Institute for Veterans Research. The registered enrollment target is 62 participants.
The verdict
NCT05367271, a Phase 2 study, has completed, sponsored by Western Institute for Veterans Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
This single-blinded, randomized-controlled trial compares the efficacy of ultrasound-guided onabotulinumtoxinA (BTX-A) injections to the flexor digitorum brevis with current standard of care corticosteroid injections to the plantar fascia for the treatment of refractory plantar fasciitis in patients that have failed six weeks of non-operative treatment.
Interventions
- DRUG Dexamethasone
- DRUG Botulinum Toxin A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2022-08-23 |
| Est. Completion | 2024-09-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05367271
The ClinicalTrials.gov registry entry for NCT05367271 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Western Institute for Veterans Research, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT05367271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05367271 about?
NCT05367271 is a clinical study titled "The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis". This single-blinded, randomized-controlled trial compares the efficacy of ultrasound-guided onabotulinumtoxinA (BTX-A) injections to the flexor digitorum brevis with current standard of care corticosteroid injections to the plantar fascia for the treatment of refractory plantar fasciitis in patients...
What is the current status of trial NCT05367271?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2022-08-23. Estimated completion is 2024-09-13.
What interventions are being tested in trial NCT05367271?
The interventions under investigation include: Dexamethasone (DRUG), Botulinum Toxin A (DRUG).
Who is sponsoring clinical trial NCT05367271?
This trial is sponsored by Western Institute for Veterans Research, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.